About JMM Formulation Private Limited
Data last updated:
JMM Formulation Private Limited is a private limited company based in Kala Amb, Himachal Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U51909HP2016PTC006427. Its GSTIN is 02AAECJ1711G1Z9 (Himachal Pradesh).
The company has an authorised share capital of ₹4.15 Cr and a paid-up capital of ₹3.94 Cr. It is led by directors including Shiv Charan and Peer Chand.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Village – Khara Khari Tehsil – Nahan, Kala Amb, Himachal Pradesh, India – 173030.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.04 Cr, a growth of 30% compared to the previous year. For the same year it recorded a net profit of ₹15.43 Lakh (net margin 0.9%) and EBITDA of ₹1.07 Cr (EBITDA margin 6.3%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 42% over five years.
As per MCA filings, the company has open charges of ₹30.27 Cr and satisfied charges of ₹2.8 Cr on record. Court records list 41 cases involving the company, including 34 filed by the company and 6 filed against it; 28 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website jmmformulation.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressVillage – Khara Khari Tehsil – Nahan, Kala Amb, Himachal Pradesh, India – 173030
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of JMM Formulation Private Limited
The main business activity of JMM Formulation is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of JMM Formulation Private Limited FY 2025 filings available
JMM Formulation Private Limited reported revenue of ₹17.04 Cr (up 30% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of JMM Formulation Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 42% over five years, including 30% growth in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of JMM Formulation Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹17.04 Cr | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.07 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹15.43 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of JMM Formulation Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of JMM Formulation are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of JMM Formulation Private Limited
JMM Formulation Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Glee Biotech Limited | ₹17.11 Cr (FY 2024) | •••• | •••• | -7.0% | •••• | New Delhi, Delhi, India |
| Vamsi Pharma Private Limited | ₹17.11 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Hyderabad, Telangana, India |
| HLL Biotech Limited | ₹17.08 Cr (FY 2024) | •••• | •••• | -68.0% | •••• | Thiruvananthapuram, Kerala, India |
| Octane Biotech Private Limited | ₹17.08 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Lucknow, Uttar Pradesh, India |
| Sagent Pharmaceuticals Private Limited | ₹17.08 Cr (FY 2025) | •••• | •••• | 434.0% | •••• | Mumbai, Maharashtra, India |
| JMM Formulation Private Limited this company | ₹17.04 Cr (FY 2025) | •••• | •••• | 30.0% | •••• | Kala Amb, Himachal Pradesh, India |
| Anchor Pharma Private Limited | ₹17.02 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Daman, Daman and Diu, India |
| Maksun Biotech Private Limited | ₹16.99 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Panchkula, Haryana, India |
| Elmed Life Sciences Private Limited | ₹16.97 Cr (FY 2025) | •••• | •••• | 48.0% | •••• | Medchal Malkajgiri, Telangana, India |
| Wonset Health Care Private Limited | ₹16.96 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Jaipur, Rajasthan, India |
| Skynox Overseas Private Limited | ₹16.96 Cr (FY 2025) | •••• | •••• | 1117.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below JMM Formulation by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of JMM Formulation Private Limited
JMM Formulation Private Limited is audited by SUDHIR CHOPRA & CO. for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SUDHIR CHOPRA & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of JMM Formulation Private Limited
JMM Formulation has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shiv Charan Also directs: Ganauli Baghwani Producer Company Limited | Director | 22 Dec 2016 | 9 Years 9 Months | Current |
| Peer Chand | Director | 22 Dec 2016 | 9 Years 9 Months | Current |
| Sushil Kumar | Director | 22 Dec 2016 | 9 Years 9 Months | Current |
| Madan Lal Also directs: Ganauli Baghwani Producer Company Limited | Director | 10 May 2018 | 8 Years 4 Months | Current |
Ownership and Shareholding of JMM Formulation Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of JMM Formulation Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Nov 2025 | Hdfc Bank Limited | ₹13.35 Cr | Open |
| 28 Apr 2025 | Axis Bank Limited | ₹2.27 Cr | Open |
| 21 Feb 2025 | Axis Bank Limited | ₹1 Cr | Open |
| 05 Sep 2023 | Axis Bank Limited | ₹2.2 Cr | Open |
| 05 Sep 2023 | Axis Bank Limited | ₹3.8 Cr | Open |
Total charge records: 9 View all charges
Legal Cases of JMM Formulation Private Limited
JMM Formulation Private Limited has 41 court cases on record: 34 filed by JMM Formulation, 6 filed against it, 1 where it is another party. 28 cases are pending and 13 are disposed. Status as checked between 29 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 41 | 6 | 28 |
Cases on record (5 of 41)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Yamunanagar, Haryana | Cheque dishonour complaint | Filed by the company against Sickcure Pharmaceuticals Private Limited | Pending |
| District court, Sirmaur, Himachal Pradesh | Execution petition | Filed by the company against Mridang Pharma Private Limited | Pending |
| District court, Sirmaur, Himachal Pradesh | Cheque dishonour complaint | Filed by the company against Sickcure Pharmaceuticals Private Limited | Pending |
| District court, Sirmaur, Himachal Pradesh | Cheque dishonour complaint | Filed by the company against Elwick Lifesciences Private Limited | Pending |
| District court, Sirmaur, Himachal Pradesh | Cheque dishonour complaint | Filed by the company against N.N Remedies Private Limited | Pending |
Full case history
All 41 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at JMM Formulation Private Limited
Employment history and EPFO contributions of people linked to JMM Formulation.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on JMM Formulation Private Limited
JMM Formulation Private Limited has 5 board changes on record since 2016: 4 appointments and 1 cessation. The latest: Madan Lal ceased to be Additional Director on 29 Sep 2018.
8 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for JMM Formulation Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by JMM Formulation Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of JMM Formulation Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of JMM Formulation Private Limited
JMM Formulation has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAECJ1711G1Z9 | Himachal Pradesh | Active | 21 Feb 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of JMM Formulation Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about JMM Formulation Private Limited
JMM Formulation is an active private limited company based in Kala Amb, Himachal Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 December 2016 (10+ years old) and is registered under CIN U51909HP2016PTC006427.
JMM Formulation reported revenue of ₹17.04 Cr for FY 2025 (up 30% YoY).
JMM Formulation has 4 current directors:
- Shiv Charan - Director
- Peer Chand - Director
- Sushil Kumar - Director
- Madan Lal - Director
JMM Formulation reported a net profit of ₹15.43 Lakh (net margin 0.9%) and EBITDA of ₹1.07 Cr (EBITDA margin 6.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of JMM Formulation is 20% over three years and 42% over five years. In the latest year (FY 2025) revenue rose 30%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of JMM Formulation is 02AAECJ1711G1Z9, registered in Himachal Pradesh.
The CIN (Corporate Identification Number) of JMM Formulation is U51909HP2016PTC006427. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
JMM Formulation has 41 court cases on record: 34 filed by the company and 6 filed against it. 28 are pending.
JMM Formulation was incorporated on 22 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
The peers of JMM Formulation by revenue are Glee Biotech Limited, Vamsi Pharma Private Limited, HLL Biotech Limited, Octane Biotech Private Limited, Sagent Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).
Madan Lal ceased to be Additional Director on 29 Sep 2018. Madan Lal was appointed as Director on 10 May 2018. Peer Chand was appointed as Director on 22 Dec 2016. JMM Formulation has 5 board changes on record in total.